Source: Annual Congress 2004 - Lung metastases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Brambilla (Grenoble, France). Systemic treatment: an adjuvant indication?. Annual Congress 2004 - Lung metastases

Member's Comments

No comment yet.

Related content which might interest you: Systemic treatment Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009 Are biphosphonates efficient in the adjuvant treatment of lung cancer? Source: Eur Respir J 2006; 28: Suppl. 50, 754s Year: 2006 Long-term oral antibiotic treatment: why, what, when and to whom? Source: Eur Respir Monogr 2017; 75: 185-205 Year: 2017 Sarcoidosis treatment and outcomes: what is most important to patients? Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes Year: 2018 More hope for cure by individualised adjuvant treatment? Source: Annual Congress 2010 - Customised chemotherapy for lung cancer Year: 2010 Duration of anticoagulant therapy: a change in the paradigm Source: International Congress 2019 – Update on anticoagulant therapy: controversy and progress Year: 2019 Systemic treatment of elderly patients Source: Eur Respir Monogr 2015; 68: 202-214 Year: 2015 Radiation therapy for post-operative recurrence: yes, but only for limited indications Source: Eur Respir J 2016; 48: 278-279 Year: 2016 Immunotherapy: when, who and which drug? Source: International Congress 2018 – New drugs, strategies and research designs for advanced non-small cell lung cancer Year: 2018